Although interferon-gamma (IFN-γ) plays a critical role in the noncytolytic elimination of many neurotropic viral infections, the signaling response to this cytokine has not been extensively characterized in primary CNS neurons. We previously demonstrated that the IFN-γ response at the signaling and gene expression levels is temporally extended in primary mouse hippocampal neurons, as compared to the transient response of primary mouse embryonic fibroblasts (MEF). We hypothesize that the protracted kinetics of STAT1 phosphorylation in IFN-γ-treated neurons are due to extended receptor activation and/or delayed STAT1 dephosphorylation in the nucleus. Here, we show that in response to IFN-γ, the Janus kinases (JAK1/JAK2) associated with the neuronal IFN-γ receptor complex remain active for an extended period as compared to MEF. Experimental inactivation of JAK1/JAK2 in neurons after IFN-γ treatment did not reverse the extended STAT1 phosphorylation phenotype. These results suggest that the extended kinetics of neuronal IFN-γ signaling are a product of distinct negative feedback mechanisms operating at both the receptor and within the nucleus.
Introduction
Interferon-gamma (IFN-γ), a key player in both the innate and adaptive arms of the immune response, induces the expression of antiviral and antibacterial response genes, and modulates the expression of genes governing immune function. Within the brain, IFN-γ plays an integral role in the clearance of neurotropic viruses (such as vesicular stomatitis virus (Komatsu et al., 1996) , measles virus (Patterson et al., 2002 ), Theiler's murine encephalomyelitis virus (Rodriguez et al., 2003) , Sindbis virus (Burdeinick-Kerr and Griffin, 2005) , and West Nile virus (Shrestha et al., 2006) ), without necessitating neuronal loss. IFN-γ is also crucial for the elimination of certain intracellular bacterial infections within the brain (Jin et al., 2004) .
A canonical view of the cellular response to IFN-γ receptor engagement has emerged (reviewed by Darnell, 1997; Stark et al., 1998) in which IFN-γ binding and subsequent assembly of its receptor complex (consisting of a heterotetramer of IFNGR1 and R2 subunits) stimulate the phosphorylation and activation of two receptor-associated kinases, Janus kinase (JAK)-1 and JAK2. This, in turn, results in the phosphorylation of multiple tyrosine residues in the cytoplasmic tails of the IFNGR1 subunits. Upon docking to the phosphorylated IFNGR1 subunit, signal transducer and activator of transcription (STAT)-1 is phosphorylated on tyrosine 701 (pY701), resulting in its homodimerization. The phospho-STAT1 homodimer is then translocated to the nucleus and binds to gamma activated sequence (GAS) elements within the promoters of IFN-γ-responsive genes, thus influencing their expression. While other signal transduction factors can respond to IFN-γ (such as STAT3), STAT1 is the primary mediator of the IFN-γ signal in most cells studied to date.
Chronic activation of the IFN-γ pathway can be cytotoxic, and therefore the cellular response is negatively regulated at two primary locations: (i) at the cell membrane, via deactivation of IFN-γ receptor-associated JAK1 and JAK2; and (ii) in the nucleus, via dephosphorylation of activated STAT1 (reviewed by Wormald et al., 2006) . These mechanisms typically involve the expression and activity of both IFN-γ-responsive proteins as well as constitutively expressed phosphatases. For example, the expression of suppressor of cytokine signaling (SOCS)-1 is induced in response to IFN-γ; it binds to IFN-γ receptor-associated JAKs and thereby prevents continued phosphorylation of the IFNGR1 subunits (Endo et al., 1997; Yasukawa et al., 1999; Giordanetto and Kroemer, 2003; Wormald et al., 2006) , effectively suppressing the response to IFN-γ at the level of the receptor. In the nucleus, the IFN-γ response is modulated by the dephosphorylation of STAT1. When dephosphorylated, the STAT1 homodimer disassembles and loses its ability to act as a transcription factor. Nuclear STAT1 phosphatase activity has been attributed to a splice isoform of TC-PTP, known as TC45 (ten Hoeve et al., 2002) . Previous studies have demonstrated that the IFN-γ response Journal of Neuroimmunology 251 (2012) 33-38 
